Free Trial

Robert W. Baird's Rating of Accendra Health on 5/12/2026

On May 12, 2026, Robert W. Baird updated its outlook on Accendra Health (NYSE:ACH) with the action "Boost Price Target", setting a price target of $6.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Robert W. Baird

DateCompanyAction
5/15/2026
CAVA Group, Inc. stock logo
CAVA
CAVA Group
Set Price Target
5/15/2026
Carvana Co. stock logo
CVNA
Carvana
Set Price Target
5/15/2026
Canada Goose Holdings Inc. stock logo
GOOS
Canada Goose
Set Price Target
5/15/2026
RideNow Group, Inc. stock logo
RDNW
RideNow Group
Boost Price Target
5/15/2026
Wolverine World Wide, Inc. stock logo
WWW
Wolverine World Wide
Lower Price Target
5/15/2026
YETI Holdings, Inc. stock logo
YETI
YETI
Boost Price Target
More Ratings From Robert W. Baird